氧化-炎症交叉声和多目标天然剂:解码糖尿病血管并发症
Jingwen Liu1, Kexin Li1, Zixin Yi1
1School of Life Science, Inner Mongolia University, Hohhot 010020, China.
Current issues in molecular biology
|August 27, 2025
概括
自然产品提供了一种多重目标的方法来对抗由氧化应激和炎症导致的糖尿病血管并发症. 这些有前途的自然疗法还需要进一步的研究.
科学领域:
- 生物医学
- 药理学
- 糖尿病学
背景情况:
- 糖尿病是一种全球性健康危机,患病率正在上升.
- 慢性高血糖会导致严重的并发症,特别是糖尿病性血管病变.
- 氧化应激和炎症是这些血管疾病的关键驱动因素.
研究的目的:
- 系统地审查导致糖尿病血管病变的病理途径.
- 探索天然产品在治疗DM并发症中的多目标治疗潜力.
- 确定自然产品临床转化中的挑战.
主要方法:
- 对糖尿病血管疾病机制的文献进行系统审查.
- 分析病理途径,包括代谢失调,线粒体功能障碍,ER压力和表观遗传学.
- 评估天然产品与单一目标合成药物的多目标协同作用.
主要成果:
- 高血糖引起的氧化应激和炎症协同驱动糖尿病血管病变.
- 多种途径 (代谢,线粒体,ER,表观遗传) 汇聚在一起促进这些病态.
- 自然产品具有多重目标作用,恢复氧化还原平衡并抑制炎症.
结论:
- 天然产品是糖尿病血管疾病的有希望的治疗策略,因为它们具有多重目标作用.
- 它们可以通过调节关键的致病网络来改善血管功能并延缓疾病的进展.
- 严格的机制研究和验证对于自然产品的成功临床转化至关重要.
相关概念视频
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Inflammatory Response I: Vascular and Cellular
12.4K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
12.4K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33


